← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:663 | 663 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1033 | 73013-1033-1 | Hydromorphone Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:663 | 663 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-293 | 70092-293-49 | Hydromorphone Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:663 | 663 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:663 | 663 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6616 | 71300-6616-2 | Ketamine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:663 | 663 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:663 | 663 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6726 | 71300-6726-2 | Lidocaine | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:663 | 663 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-118 | 73177-118-03 | Lidocaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:664 | 664 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-139 | 63037-139-25 | Neostigmine Methylsulfate | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:664 | 664 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:664 | 664 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycerin; Epinephrine; Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:664 | 664 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6084 | 71286-6084-1 | Glycopyrrolate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:664 | 664 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-790 | 76154-790-73 | Glycopyrrolate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:664 | 664 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:664 | 664 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:664 | 664 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-120 | 70092-120-43 | Ketamine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:664 | 664 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9070 | 71266-9070-1 | Ketamine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:664 | 664 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:664 | 664 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2013 | 71286-2013-2 | Hydromorphone Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:664 | 664 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:664 | 664 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9080 | 71266-9080-1 | Ketamine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:664 | 664 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:664 | 664 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-111 | 73702-111-15 | Lidocaine | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:664 | 664 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:665 | 665 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-475 | 70092-475-50 | Dextrose PF 500mg/ml 50ml SWFI syr | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:665 | 665 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:665 | 665 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2416 | 72627-2416-1 | Glycine | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:665 | 665 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-104 | 71449-104-07 | Glycopyrrolate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:665 | 665 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-792 | 76154-792-75 | Glycopyrrolate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:665 | 665 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:665 | 665 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-4272 | 60652-4272-1 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:665 | 665 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-3020 | 71286-3020-1 | Ketamine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:665 | 665 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:665 | 665 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1035 | 73013-1035-1 | Hydromorphone Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:665 | 665 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2013 | 71286-2013-1 | Hydromorphone Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:665 | 665 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-2015 | 73013-2015-1 | Ketamine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:665 | 665 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9080 | 71266-9080-2 | Ketamine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:665 | 665 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-308 | 69374-308-05 | Ketamine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:665 | 665 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:665 | 665 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9100 | 71266-9100-3 | Lidocaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:666 | 666 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0406 | 71285-0406-1 | Trophamine 3.5% / Dextrose 10% 250ml in 250ml bag | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:666 | 666 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:666 | 666 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1373 | 61141-1373-5 | Glycopyrrolate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:666 | 666 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-104 | 71449-104-11 | Glycopyrrolate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:666 | 666 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0740 | 5446-0740-01 | Glycopyrrolate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:666 | 666 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:666 | 666 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fluoxetine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:666 | 666 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-521 | 69374-521-31 | Ketamine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:666 | 666 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:666 | 666 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1030 | 73013-1030-1 | Hydromorphone Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:666 | 666 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2011 | 71286-2011-1 | Hydromorphone Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:666 | 666 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-2016 | 73013-2016-1 | Ketamine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:666 | 666 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-2002 | 73013-2002-2 | Ketamine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:666 | 666 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-050 | 71506-050-56 | Ketamine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:666 | 666 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-110 | 73177-110-12 | Lidocaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:666 | 666 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9090 | 71266-9090-9 | Lidocaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:667 | 667 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4538 | 61141-4538-4 | Povidone-Iodine Repak 5%, 0.4ml in syringe | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:667 | 667 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:667 | 667 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-009 | 71449-009-07 | Glycopyrrolate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:667 | 667 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6084 | 72196-6084-1 | Glycopyrrolate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:667 | 667 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2004 | 71266-2004-1 | Glycopyrrolate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:667 | 667 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:667 | 667 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fluoxetine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:667 | 667 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-4001 | 72627-4001-2 | Ketamine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:667 | 667 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-4010 | 72627-4010-9 | Ketamine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:667 | 667 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1045 | 73013-1045-1 | Hydromorphone Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:667 | 667 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2012 | 71286-2012-1 | Hydromorphone Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:667 | 667 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-136 | 63037-136-25 | Ketamine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:667 | 667 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:667 | 667 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-074 | 71506-074-05 | Ketamine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:667 | 667 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-120 | 73177-120-02 | Lidocaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:667 | 667 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9090 | 71266-9090-1 | Lidocaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:668 | 668 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6442 | 71300-6442-2 | Ketoprofen | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:668 | 668 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:668 | 668 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-903 | 69374-903-03 | Glycopyrrolate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:668 | 668 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3325 | 62295-3325-5 | Glycopyrrolate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:668 | 668 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2004 | 71266-2004-2 | Glycopyrrolate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:668 | 668 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:668 | 668 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Flurbiprofen | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:668 | 668 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-4009 | 72627-4009-9 | Ketamine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:668 | 668 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-4003 | 72627-4003-7 | Ketamine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:668 | 668 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:668 | 668 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:668 | 668 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-563 | 70092-563-43 | Ketamine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:668 | 668 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:668 | 668 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1213 | 73271-1213-1 | Ketoconazole | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:668 | 668 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9091 | 71266-9091-1 | Lidocaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:668 | 668 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-175 | 70092-175-46 | Lidocaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:669 | 669 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-3006 | 79559-3006-1 | S-E006 | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:669 | 669 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:669 | 669 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-903 | 69374-903-05 | Glycopyrrolate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:669 | 669 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-781 | 76154-781-73 | Glycopyrrolate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:669 | 669 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-109 | 73702-109-15 | Glycopyrrolate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:669 | 669 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:669 | 669 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-013 | 79926-013-03 | Flurbiprofen Sodium | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:669 | 669 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-4000 | 72627-4000-2 | Ketamine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:669 | 669 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-4001 | 72627-4001-2 | Ketamine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:669 | 669 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:669 | 669 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:669 | 669 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:669 | 669 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:669 | 669 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2503 | 72934-2503-2 | Ketoconazole; Hydrocortisone | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:669 | 669 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6006 | 72196-6006-1 | Lidocaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:669 | 669 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0001 | 81483-0001-1 | Lidocaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:670 | 670 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-145 | 73177-145-31 | Theophylline | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:670 | 670 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6004 | 71286-6004-1 | Ephedrine Sulfate | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:670 | 670 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:670 | 670 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-782 | 76154-782-75 | Glycopyrrolate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:670 | 670 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-109 | 73702-109-32 | Glycopyrrolate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:670 | 670 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:670 | 670 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fomepizole | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:670 | 670 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-511 | 69374-511-01 | Ketamine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:670 | 670 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-4009 | 72627-4009-9 | Ketamine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:670 | 670 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:670 | 670 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:670 | 670 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73463-103 | 73463-103-06 | Ketamine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:670 | 670 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1213 | 73271-1213-1 | Ketoconazole | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:670 | 670 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2504 | 72934-2504-2 | Ketoconazole; Hydrocortisone; Iodoquinol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:670 | 670 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:670 | 670 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9092 | 71266-9092-1 | Lidocaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:671 | 671 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-017 | 71506-017-59 | Vancomycin Hydrochloride | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:671 | 671 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6003 | 71286-6003-1 | Ephedrine Sulfate | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:671 | 671 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:671 | 671 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:671 | 671 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Guaifenesin | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:671 | 671 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:671 | 671 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0006 | 81483-0006-0 | Furosemide | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:671 | 671 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-3022 | 71286-3022-1 | Ketamine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:671 | 671 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-4000 | 72627-4000-2 | Ketamine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:671 | 671 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1041 | 73013-1041-1 | Hydromorphone Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:671 | 671 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:671 | 671 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-137 | 63037-137-25 | Ketamine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:671 | 671 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2369 | 72934-2369-2 | Ketoconazole; Hydrocortisone | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:671 | 671 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2616 | 72934-2616-2 | Ketoconazole; Niacinamide | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:671 | 671 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0000 | 81483-0000-0 | Lidocaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:671 | 671 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0000 | 81483-0000-0 | Lidocaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:672 | 672 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0010 | 73271-0010-1 | ESTRADIOL 10 PEL | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:672 | 672 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6003 | 71286-6003-2 | Ephedrine Sulfate | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:672 | 672 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6084 | 71286-6084-1 | Glycopyrrolate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:672 | 672 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0740 | 5446-0740-01 | Glycopyrrolate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:672 | 672 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-540 | 68985-540-91 | Heparin Sodium | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:672 | 672 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:672 | 672 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-043 | 79926-043-11 | Gabapentin | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:672 | 672 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:672 | 672 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-137 | 63037-137-25 | Ketamine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:672 | 672 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:672 | 672 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:672 | 672 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73463-100 | 73463-100-01 | Ketamine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:672 | 672 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2370 | 72934-2370-2 | Ketoconazole; Hydrocortisone; Iodoquinol | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:672 | 672 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6442 | 71300-6442-2 | Ketoprofen | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:672 | 672 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0000 | 81483-0000-1 | Lidocaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:672 | 672 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-740 | 69194-740-01 | Lidocaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:673 | 673 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5112 | 26436-5112-5 | Trimix 40/30/3 | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:673 | 673 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:673 | 673 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:673 | 673 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:673 | 673 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-540 | 68985-540-95 | Heparin Sodium | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:673 | 673 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:673 | 673 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-043 | 79926-043-10 | Gabapentin | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:673 | 673 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:673 | 673 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-136 | 63037-136-25 | Ketamine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:673 | 673 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-112 | 70092-112-49 | Hydromorphone Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:673 | 673 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:673 | 673 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73463-102 | 73463-102-03 | Ketamine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:673 | 673 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2363 | 72934-2363-2 | Ketoconazole; Niacinamide | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:673 | 673 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6627 | 71300-6627-2 | Ketoprofen | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:673 | 673 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:673 | 673 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:674 | 674 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5580 | 26436-5580-1 | Phenol | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:674 | 674 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:674 | 674 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-781 | 76154-781-73 | Glycopyrrolate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:674 | 674 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:674 | 674 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7022 | 72196-7022-1 | Heparin Sodium | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:674 | 674 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:674 | 674 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Gabapentin | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:674 | 674 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-2000 | 73013-2000-1 | Ketamine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:674 | 674 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-120 | 70092-120-43 | Ketamine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:674 | 674 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-117 | 70092-117-79 | Hydromorphone Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:674 | 674 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:674 | 674 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:674 | 674 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6442 | 71300-6442-2 | Ketoprofen | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:674 | 674 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-123 | 69852-123-10 | Ketorolac Tromethamine | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:674 | 674 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-740 | 69194-740-01 | Lidocaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:674 | 674 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-443 | 70092-443-43 | Lidocaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:675 | 675 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-090 | 71449-090-42 | Lidocaine Hydrochloride, Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:675 | 675 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:675 | 675 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-782 | 76154-782-75 | Glycopyrrolate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:675 | 675 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-790 | 76154-790-73 | Glycopyrrolate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:675 | 675 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7023 | 72196-7023-1 | Heparin Sodium | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:675 | 675 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:675 | 675 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-042 | 79926-042-10 | Gabapentin | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:675 | 675 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-2000 | 73013-2000-2 | Ketamine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:675 | 675 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-4003 | 72627-4003-3 | Ketamine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:675 | 675 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-290 | 70092-290-49 | Hydromorphone Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:675 | 675 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:675 | 675 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:675 | 675 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6627 | 71300-6627-2 | Ketoprofen | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:675 | 675 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketorolac Tromethamine; Epinephrine; Clonidine Hydrochloride; Ropivacaine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:675 | 675 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:675 | 675 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-098 | 73198-098-30 | Lidocaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:676 | 676 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-104 | 71449-104-11 | Glycopyrrolate | 2025-2 | valid | 0 | 2026-09-18 |